Triple anti-viral drug shows COVID-19 promise in Hong Kong study

May 15, 2020

Triple anti-viral drug shows COVID-19 promise in Hong Kong study

Posted by Saúl Morales Rodriguéz in category: biotech/medical

Drug trio allows patients with milder symptoms to recover quicker than those treated with single drug, new study says.

Leave a reply

GETAS THREAT LEVEL: GUARDED
TOP DONOR: BRIAN CARTMELL
#2 DONOR: DONALD MACLEAN
#3 DONOR: JEFF BONE/TOPSIGHT FUND
#4 DONOR: PEG KAY

LF FUND: $601,282.98
BITCOIN ENDOWMENT: $8,044,844.62
A-PRIZE: $30,015.00
NANOSHIELD: $17,018.00
X-RISKS NETWORK: $3,108.00
AISHIELD: $4,114.00

LIFEBOAT NEWS: 3,048 SUBSCRIBERS
GETAS ALERTS: 439 SUBSCRIBERS
BLOG: 51,536 POSTS
BOARDS: 2,852 MEMBERS
REPORTS: 55
PROGRAMS: 25
FORUMS: 13
QUOTES: 136

FACEBOOK: 8,341 MEMBERS
LINKEDIN: 1,983 MEMBERS
TWITTER FEED: 32,811 MEMBERS
FIGHT AIDS: 3 MEMBERS
[email protected]: 15 MEMBERS
[email protected]: 44 MEMBERS
A-PRIZE: 55 MEMBERS
NANOSHIELD: 69 MEMBERS
AISHIELD: 25 MEMBERS

DONORS: 4,072
LF-500: 13 MEMBERS
PATRON: 1 MEMBER
FIRST CLASS: 1 MEMBER
EXECUTIVE: 12 MEMBERS
ECONOMY: 23 MEMBERS
A-500: 1 MEMBER

© 2002–2020 Lifeboat Foundation